Skip to main content
Equibles
SOLV logo

SOLV · Solventum Corp

Track SOLV — free

Use SOLV with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$92.44 +0.54 (+0.59%) At close · Sep 3
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$15.72B
Shares
170.22M

SOLV metrics

83 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$92.44
Market cap
$15.72B

Price action

19 metrics
Price change (1W)
+0.4%
Price change (30D)
+4.5%
Price change (3M)
+17.3%
Price change (6M)
+30.5%
Price change (YTD)
+16.0%
Price change (1Y)
+28.0%
Trailing year
Price change (5Y)
—
52-week high
$91.90
52-week low
$62.49
Change from 52-week high
+0.0%
Change from 52-week low
+47.1%
Annualized volatility
29.9%
Beta
0.6
RSI (14D)
66.8
Price vs SMA 50
+10.2%
Price vs SMA 200
+19.0%
Avg volume (3M)
1.27M
Relative volume
0.7
Average dollar volume
$104.25M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
170.22M

Valuation

12 metrics
P / E (TTM)
11.2
Trailing earnings · reciprocal yield 8.9%
PEG ratio
2.9
EV / revenue
2.5×
reciprocal yield 40.7%
EV / EBITDA
7.9×
reciprocal yield 12.7%
EV / EBIT
9.8×
reciprocal yield 10.2%
P / sales
1.9×
reciprocal yield 52.9%
P / book
3.3
reciprocal yield 30.5%
FCF yield
-0.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
75.2
reciprocal yield 1.3%
Earnings yield
9.1%

Historical valuation

8 metrics
P / E historical average (3Y)
18.6×
reciprocal yield 5.4%
P / E historical average (5Y)
18.6×
reciprocal yield 5.4%
EV / revenue historical average (3Y)
2.2×
reciprocal yield 45.6%
EV / revenue historical average (5Y)
2.2×
reciprocal yield 45.6%
EV / EBIT historical average (3Y)
14.5×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
14.5×
reciprocal yield 6.9%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
54.7%
Operating margin
25.0%
Trailing 12 months
Net margin
17.3%
Gross profit (TTM)
$4.54B
Operating profit (TTM)
$2.08B
Net income (TTM)
$1.43B
Trailing 12 months
Diluted EPS (TTM)
$8.19
FCF margin
-1.4%
Effective tax rate
15.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.48

Growth

11 metrics
Revenue growth YoY
+2.2%
Year over year
Net income growth YoY
+2.2%
Revenue (TTM)
$8.31B
Trailing 12 months
EPS growth YoY
+3.9%
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+0.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+4.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
29.9%
Return on assets
10.1%
Debt / equity
1.1
Current ratio
1.0
EBITDA (TTM)
$2.58B
Free cash flow (TTM)
−$118.00M
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
1.8
Return on invested capital
18.5%
Trailing 12 months
Net cash
−$4.68B
Latest balance sheet
Cash & equivalents
$403.00M
Total assets
$14.24B
Total debt
$5.08B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$209.00M
Capital expenditures (TTM)
$327.00M
R&D (TTM)
$724.00M
SG&A (TTM)
$3.29B
Stock compensation (TTM)
$167.00M
R&D / revenue
8.7%
Stock compensation / revenue
2.0%

Ownership (13F)

3 metrics
13F filers
880
13F filer change QoQ
-7
Institutional ownership
75.2%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1964738 CUSIP 83444M101 13F (30d) 532 filings 519 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)